Patents by Inventor Gil Bu Kang

Gil Bu Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR REMOVING FXI WHEN PURIFYING PLASMA PROTEINS
    Publication number: 20210363179
    Abstract: Disclosed is a method for removing factor XI (FXI) during plasma protein purification, more specifically a method for removing FXI including dialyzing and concentrating a plasma protein fraction II paste containing FXI and a plasma protein, and then removing the FXI using a ceramic-based cation exchange resin. The method for removing factor XI (FXI) can improve removal efficiency of impurities and thrombogenic substances, thereby producing stable plasma proteins with improved quality.
    Type: Application
    Filed: August 4, 2021
    Publication date: November 25, 2021
    Inventors: Dae-eun KANG, Gil Bu KANG, Seol Young YOO, Jihye LEE, Ki-Yong KIM, Soo-kwang KIM
  • METHOD FOR REMOVING FXI WHEN PURIFYING PLASMA PROTEINS
    Publication number: 20190367557
    Abstract: Disclosed is a method for removing factor XI (FXI) during plasma protein purification, more specifically a method for removing FXI including dialyzing and concentrating a plasma protein fraction II paste containing FXI and a plasma protein, and then removing the FXI using a ceramic-based cation exchange resin. The method for removing factor XI (FXI) can improve removal efficiency of impurities and thrombogenic substances, thereby producing stable plasma proteins with improved quality.
    Type: Application
    Filed: October 17, 2017
    Publication date: December 5, 2019
    Inventors: Dae-eun KANG, Gil Bu KANG, Seol Young YOO, Jihye LEE, Ki-Yong KIM, Soo-kwang KIM
  • Method of purifying a long-acting human growth hormone
    Patent number: 9902753
    Abstract: The present invention relates to a long-acting human growth hormone NexP-hGH protein and its production method. More specifically, it relates to a specific isoform of long-acting human growth hormone NexP-hGH protein in which human growth hormone is fused with a highly glycosylated alpha-1 antitrypsin mutant whereby long-acting properties in vivo are increased.
    Type: Grant
    Filed: June 5, 2013
    Date of Patent: February 27, 2018
    Assignees: CJ HEALTHCARE CORPORATION, ALTEOGEN, INC
    Inventors: Gil Bu Kang, Chung Min Lee, Jee Won Ahn, Dong Eok Lee, Chang Bong Jun, Won Jeong Lee, Sung Yoo Cho, Chi Hye Park, Ki Wan Kim, Yoon Jung Lee, Ji Hyun Moon, Hoo Keun Oh, Young Joon Park, Sang Hyun Lee, Hyoung Taek Lim, Soon Jae Park, Hye Shin Chung, Sang Mee Lee
  • Highly Glycosylated Long-Acting Human Growth Hormone Protein and Production Method for Same
    Publication number: 20150126715
    Abstract: The present invention relates to a long-acting human growth hormone NexP-hGH protein and its production method. More specifically, it relates to a specific isoform of long-acting human growth hormone NexP-hGH protein in which human growth hormone is fused with a highly glycosylated alpha-1 antitrypsin mutant whereby long-acting properties in vivo are increased.
    Type: Application
    Filed: June 5, 2013
    Publication date: May 7, 2015
    Inventors: Gil Bu Kang, Chung Min Lee, Jee Won Ahn, Dong Eok Lee, Chang Bong Jun, Won Jeong Lee, Sung Yoo Cho, Chi Hye Park, Ki Wan Kim, Yoon Jung Lee, Ji Hyun Moon, Hoo Keun Oh, Young Joon Park, Sang Hyun Lee, Hyoung Taek Lim, Soon Jae Park, Hye Shin Chung, Sang Mee Lee